NYSE:WMB

Williams Companies (NYSE:WMB) Stock Analysis: Price Target, Valuation, and Growth Prospects

Font: Financial Modeling Prep  • Jul 14, 2026

Market Chart
  • Price Target Update: CIBC adjusted its price target for Williams Companies to $83, still indicating potential upside from its trading price of $75.42.
  • Strategic Investment: Williams Companies secured a $5.34 billion investment from Blackstone for AI-driven Power Innovation projects, reducing capital needs while maintaining 51% ownership.
  • Valuation Concerns: GuruFocus suggests Williams Companies is overvalued at $75.08, 23.5% above its estimated fair value of $60.81, alongside recent insider selling of $5.30 million.

Williams Companies (NYSE:WMB) is a major energy infrastructure company. It plays a key role in the natural gas sector, handling about one-third of all natural gas used in the United States. The company operates in a market with peers like Antero Resources (NYSE: AR) and Expand Energy, facing similar industry trends.

On July 14, 2026, CIBC (NYSE: CM) adjusted its price target for Williams Companies to $83 from $85. A price target is an analyst's estimate of a stock's future value. When this target was set, the stock was trading at $75.42, suggesting the analyst still sees potential for the stock's price to increase.

This adjustment comes as Williams Companies secures a $5.34 billion investment led by Blackstone (NYSE: BX) for its Power Innovation projects. The deal, aimed at meeting rising electricity demand from artificial intelligence, reduces Williams Companies' need for capital. The company maintains a 51% ownership and operational control of these projects.

As highlighted by Zacks Investment Research, Williams Companies faces near-term challenges from falling natural gas prices. However, the long-term view is more positive, supported by strong electricity demand and recovering exports. The company is also pursuing major expansion projects to meet this expected growth in demand.

A GuruFocus analysis suggests Williams Companies is overvalued, with its price of $75.08 being 23.5% above its estimated fair value of $60.81. The report also notes that company insiders sold $5.30 million in shares over the last three months, with no insider buying activity reported during that same period.

Market Overview
TRUG
TruGolf Holdings, Inc.
$0.65
76.14%
SURG
SurgePays, Inc.
$0.17
5.23%
BDRX
Biodexa Pharmaceuticals Plc
$1.30
96.94%
KHC
The Kraft Heinz Company
$24.60
0.86%
ACVA
ACV Auctions Inc.
$10.41
44.18%
TNON
Tenon Medical, Inc.
$5.93
11.89%
ETHA
iShares Ethereum Trust ETF
$19.16
3.23%
SMR
NuScale Power Corporation
$8.60
-15.73%
NVDA
NVIDIA Corporation
$218.29
-0.03%
INTC
Intel Corp.
$102.94
2.61%